Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001753926-23-001491
Filing Date
2023-11-14
Accepted
2023-11-14 16:11:36
Documents
62
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tlcc-20230930.htm   iXBRL 10-Q 1572789
7 EXHIBIT 31.1 ex311_1.htm EX-31.1 12906
8 EXHIBIT 32.1 ex321_2.htm EX-32.1 7170
  Complete submission text file 0001753926-23-001491.txt   8003390

Data Files

Seq Description Document Type Size
2 DEFINITION tlcc-20230930_def.xml EX-101.DEF 271723
3 PRESENTATION tlcc-20230930_pre.xml EX-101.PRE 430264
4 CALCULATION tlcc-20230930_cal.xml EX-101.CAL 99672
5 LABEL tlcc-20230930_lab.xml EX-101.LAB 736634
6 SCHEMA tlcc-20230930.xsd EX-101.SCH 52293
56 EXTRACTED XBRL INSTANCE DOCUMENT tlcc-20230930_htm.xml XML 1384231
Mailing Address 4800 T-REX AVENUE SUITE 305 BOCA RATON FL 33431
Business Address 4800 T-REX AVENUE SUITE 305 BOCA RATON FL 33431 561-443-5001
TWINLAB CONSOLIDATED HOLDINGS, INC. (Filer) CIK: 0001590695 (see all company filings)

EIN.: 463951742 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55181 | Film No.: 231406252
SIC: 2833 Medicinal Chemicals & Botanical Products